UK and US Launch Human Trials for mRNA Bird Flu Vaccine Amid Pandemic Concerns

15 articles · Updated · The Washington Post · Apr 22

A large-scale human trial of an mRNA bird flu vaccine has begun in the UK and US, targeting the H5N1 strain.
The Moderna-developed vaccine uses technology similar to Covid-19 jabs and will involve 4,000 volunteers, especially poultry workers and older adults.
Experts warn H5N1 is evolving and spreading among animals, and this proactive trial aims to boost pandemic preparedness amid concerns of possible human transmission.

Moderna's vaccine trial has started, but can it be ready before the bird flu virus outsmarts us?

As H5N1 spreads in cattle, is a human vaccine enough, or is the real problem on our farms?

The H5N1 vaccine trial is here, but is declining global health funding making a future pandemic inevitable?

Could your seasonal flu shot offer surprising protection against a deadly H5N1 bird flu outbreak?

Can Moderna's UK facility prevent the vaccine hoarding that plagued the world during the last pandemic?

Beyond vaccines, what overlooked treatments could be our secret weapon against a bird flu pandemic?